CAY10585, HIF-1alpha inhibitor and 1 more item

The University of Virginia awarded a contract to Epitomics Inc. on June 16, 2026, with a cumulative contract value of $252. The prime contractor will deliver specialized chemical compounds to Saainikedhana Venugopal at the University of Virginia in Virginia. The contract encompasses two distinct line items: CAY10585, a hypoxia-inducible factor 1-alpha (HIF-1alpha) inhibitor priced at $143.55 per unit, and Dimethyl-bisphenol A, a HIF-1alpha inhibitor priced at $108.90 per unit, with one unit ordered for each item.

This procurement represents a purchase of research-grade chemical reagents, likely supporting scientific research activities at the University of Virginia. The low aggregate contract value and modest quantities suggest this award is for small-scale laboratory supplies rather than a comprehensive research services engagement. No specific period of performance dates beyond the award date of June 16, 2026, are provided in the contract documentation.